5803-22-5

Usage

Uses

Used in Pharmaceutical Industry:
MNPA is utilized as an active pharmaceutical ingredient for the development of new drugs with anti-inflammatory and analgesic effects. Its properties make it suitable for the treatment of various conditions characterized by pain and inflammation.
Used in Agrochemical Industry:
MNPA serves as an intermediate in the synthesis of agrochemicals, contributing to the development of products designed to protect crops from pests and diseases, thereby enhancing agricultural productivity.
Used in Organic Compounds Production:
As an intermediate, MNPA is involved in the production of various organic compounds, highlighting its versatility and applicability in multiple chemical reactions and processes.
Used in Research and Development:
MNPA is employed in research settings to explore its potential applications and to understand its chemical behavior, thereby contributing to the advancement of scientific knowledge and the creation of innovative products and applications.

Upstream product

• 104103-16-4 (3-Methoxy-4-nitro-phenyl)-acetonitrile 
• 448-19-1 4-fluoro-2-methoxy-1-nitrobenzene 
• 19924-43-7 3-methoxyphenylacetonitrile 

Downstream Products

• 168766-15-2 2-(3-methoxy-4-nitrophenyl)ethanol 
• 862855-92-3 2-[3-methoxy-4-nitrophenyl]acetamide 
• 230648-62-1 2-(4-amino-3-methoxyphenyl)acetic acid 
• 1315513-56-4 2-methoxy-4-(2-(pyrrolidin-1-yl)ethyl)benzenamine 
• 1386950-26-0 2-(4-amino-3-methoxyphenyl)-1-(pyrrolidin-1-yl)ethanone 
• 1386950-24-8 2-(3-methoxy-4-nitrophenyl)-1-(pyrrolidin-1-yl)ethanone 
• 306284-03-7 (3-methoxy-4-nitro)phenylacetyl chloride 
• 162663-13-0 methyl 2-(3-methoxy-4-nitrophenyl)acetate 
• 949495-67-4 C₂₉H₂₆N₂O₁₀ 
• 949495-64-1 ethyl ({2-methoxy-4-[2-({5-hydroxy-2-[(4-methoxybenzylamino)carbonyl]-4-oxo-4H-chromen-7-yl}oxy)ethyl]phenyl}amino)(oxo)acetate 
• 949495-58-3 ethyl 7-[2-(3-methoxy-4-{[ethoxy(oxo)acetyl]amino}phenyl)ethoxy]-5-hydroxy-4-oxo-4H-chromene-2-carboxylate 
• 949495-55-0 ethyl {[4-(2-hydroxyethyl)-2-methoxyphenyl]amino}(oxo)acetate 
• 949495-54-9 ethyl ({2-methoxy-4-[2-(tetrahydro-2H-pyran-2-yloxy)ethyl]phenyl}amino)(oxo)acetate 
• 949495-53-8 {2-methoxy-4-[2-(tetrahydro-2H-pyran-2-yloxy)ethyl]phenyl}amine 

Relevant academic research and scientific papers

BICYCLIC INHIBITORS OF ALK

The present invention relates to compounds of formula (1) or pharmaceutical acceptable salts, wherein R1, X, Y, Z, A, B, G1, and n are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as ALK and methods of treating diseases such as cancer.

BICYCLIC CARBOXAMIDE INHIBITORS OF KINASES

Compounds of formula (I) or pharmaceutical acceptable salts are provided, wherein X1~X5, R1~R3, A, B, Z and n are defined in the description. And compositions containing said compounds, and the uses for inhibitors of kinases such as ALK, and the uses for treating cancer thereof are provided.

Design, synthesis, and biological evaluation of Plasmodium falciparum lactate dehydrogenase inhibitors

Plasmodium falciparum lactate dehydrogenase (pfLDH) is a key enzyme for energy generation of malarial parasites and is a potential antimalarial chemotherapeutic target. It is known that the oxamate moiety, a pyruvate analog, alone shows higher inhibition

ALPHA-4 INTEGRIN MEDIATED CELL ADHESION INHIBITORS FOR THE TREATMENT OR PREVENTION OF INFLAMMATORY DISEASES

The present invention relates to novel compounds of formula (I), processes for their preparation, compositions comprising them and their use in the treatment or prevention of diseases capable of being modulated by the inhibition of cell adhesion.